1: LEGNANI C, CINI M, COSMI B, FILIPPINI M, FAVARETTO E,
PALARETI G. Inherited and
acquired thrombophilic alterations in patients with superficial
vein thrombosis of lower
limbs. Thromb Haemost. 2014 Feb 6;111(6). [Epub ahead of
print] PubMed PMID: 24500135.
2: CINI M, LEGNANI C, FRASCARO M, SARTORI M, COSMI B,
PALARETI G. D-dimer use for deep venous thrombosis exclusion in elderly
patients: a comparative analysis of three different approaches to establish
cut-off values for an assay with results expressed in D-dimer units. Int J Lab Hematol. 2014 Jan 16.
doi: 10.1111/ijlh.12184.
[Epub ahead of print] PubMed PMID: 24428869.
3: POLI D, ANTONUCCI E, TESTA S, COSMI B, PALARETI G, AGENO
W. The predictive ability of bleeding risk stratification
models in very old patients on vitamin K antagonist treatment for venous
thromboembolism: results of the prospective collaborative EPICA study: reply. J Thromb
Haemost. 2014 Jan 10. doi: 10.1111/jth.12502. [Epub ahead of print]
PubMed PMID: 24405549.
4: COSMI B, FILIPPINI M, CAMPANA F, AVRUSCIO G, GHIRARDUZZI
A, BUCHERINI E, CAMPORESE
G, IMBERTI D, LEGNANI C, PALARETI G; STEFLUX Investigators.
Risk factors for recurrent events in subjects with
superficial vein thrombosis in the randomized clinical trial SteFlux
(Superficial Thromboembolism Fluxum). Thromb Res. 2014 Feb;133(2):196-202. doi:
10.1016/j.thromres.2013.12.005. Epub 2013 Dec 7. PubMed PMID: 24365043.
5: DONADINI MP, AGENO W, ANTONUCCI E, COSMI B, KOVACS MJ, LE
GAL G, OCKELFORD P, POLI D, PRANDONI P, RODGER M, SACCULLO G,
SIRAGUSA S, YOUNG L, BONZINI M, CAPRIOLI M, DENTALI F, IORIO A,
DOUKETIS JD. Prognostic significance of residual venous obstruction
in patients with treated unprovoked deep vein thrombosis:
a patient-level
meta-analysis. Thromb Haemost. 2014 Jan;111(1):172-9.
doi:10.1160/TH13-04-0336. Epub
2013 Oct 24. PubMed PMID: 24154729.
6: POLI D, ANTONUCCI E, TESTA S, COSMI B, PALARETI G, AGENO
W; FCSA ITALIAN FEDERATION OF ANTICOAGULATION CLINICS.
The predictive ability of bleeding risk stratification models in
very old patients on vitamin K antagonist treatment for
venous thromboembolism: results of the prospective collaborative
EPICA study. JThromb Haemost.
2013 Jun;11(6):1053-8. doi: 10.1111/jth.12239. PubMed
PMID:23578305.
7: COSMI B, LEGNANI C, PENGO V, GHIRARDUZZI A, TESTA S, POLI
D, PRISCO D, TRIPODI A, PALARETI G; PROLONG INVESTIGATORS (ON
BEHALF OF FCSA, ITALIAN FEDERATION OF ANTICOAGULATION CLINICS). The
influence of factor V Leiden and G20210A prothrombin mutation on
the presence of residual vein obstruction after idiopathic
deep-vein thrombosis of the lower limbs. Thromb Haemost.
2013Mar;109(3):510-6. doi:
10.1160/TH12-01-0041. Epub 2013 Jan 10. PubMed
PMID: 23306310.
8: CINI M, LEGNANI C, COSMI B, GUAZZALOCA G, VALDRÈ L,
FRASCARO M, PALARETI G. The influence of VKORC1 3730 G > A
polymorphism on warfarin dose: reply. Eur J Clin Pharmacol. 2013
Apr;69(4):1045. doi: 10.1007/s00228-012-1431-2. Epub 2012 Oct 12.
PubMed PMID: 23064486.
9: DI NISIO M, BAUDO F, COSMI B, D'ANGELO A, DE GASPERI A,
MALATO A, SCHIAVONI M, SQUIZZATO A, ITALIAN SOCIETY FOR THROMBOSIS
AND HAEMOSTASIS.
(2012). Diagnosis and treatment of disseminated intravascular
coagulation: guidelines of the Italian Society for Haemostasis and
Thrombosis (SISET). THROMBOSIS RESEARCH, vol. 129, p. e177-e184,
ISSN: 0049-3848
10: PRANDONI P, NOVENTA F, QUINTAVALLA R, BOVA C, COSMI B,
SIRAGUSA S, BUCHERINI E, ASTORRI F, CUPPINI S, DALLA VALLE F,
LENSING AW, PRINS MH, VILLALTA S, CANANO INVESTIGATORS,
COLLABORATORS: VEDOVETTO V, BARBAR S, CAMPELLO E, MILAN M, FILIPPI
L, ROCCI A, CHIAPPETTA P, PELLEGRINI R, FIASCHI E, VALLONE G,
D'AMICO E, NOTO A, PILI C, COSTANTINI E, GASPERON M, PALARETI G,
MALATO A, SACCULLO G, BRINI C, BITTI G, MARZOLO M, RAMAZZINA
E,ZAMBONI S. (2012). Thigh-length versus below-knee compression
elastic stockings for prevention of the postthrombotic syndrome in
patients with proximal-venous thrombosis: a randomized trial.
BLOOD, vol. 119, p. 1561-1565, ISSN: 0006-4971
11: Cosmi B, Alatri A, Cattaneo M, Gresele P, Marietta
M, Rodeghiero F, Tripodi A, Ansaloni L, Fusari M, Taddei S.
Assessment of the risk of bleeding in patients undergoing surgery
or invasive procedures on behalf of the Italian Society for
Thrombosis and Haemostasis (SISET: Società Italiana per lo Studio
dell'Emostasi e della Trombosi). Thromb Res. 2009 Sep 7. [Epub
ahead of print] PubMed PMID:19740528.
12: Palareti G, Cosmi B. Bleeding with anticoagulation therapy -
who is at risk,and how best to identify such patients. Thromb
Haemost. 2009 Aug;102(2):268-78.PubMed PMID: 19652877.
13: Iorio A, Ageno W, Cosmi B, Imberti D, Lussana F, Siragusa S,
Tormene D,Tosetto A, Cattaneo M. Guidelines of the Italian Society
for Haemostasis and Thrombosis: Objectives and methodology. Thromb
Res. 2009 Jun 25. [Epub ahead of print] PubMed PMID: 19559468.
14: Cosmi B. ARC-1779, a PEGylated aptamer antagonist of von
Willebrand factor for potential use as an anticoagulant or
antithrombotic agent. Curr Opin Mol Ther. 2009 Jun;11(3):322-8.
PubMed PMID: 19479665.
15: Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A,
Alatri A, Prisco D, Poli D, Tripodi A, Palareti G. Use of D-dimer
testing to determine duration of anticoagulation, risk of
cardiovascular events and occult cancer after a first
episode of idiopathic venous thromboembolism: the extended
follow-up of the PROLONG study. J Thromb Thrombolysis. 2009 Mar 14.
[Epub ahead of print] PubMed PMID: 19288181.
16: Cosmi B. ACP Journal Club. Review: Low-molecular-weight
heparin reduces risk for venous thromboembolism in adults with leg
immobilization. Ann Intern Med. 2009 Feb 17;150(4):JC2-4. PubMed
PMID: 19238602.
17. Cosmi B. Review: recombinant factor VIIa does
not differ from placebo for prevention or treatment of bleeding in
patients without hemophilia. ACP J Club. 2007
Nov-Dec;147(3):70.
